Over the past few years, several new, highly effective treatment strategies have improved survival outcomes in patients with early breast cancer. “We’ve been very fortunate” to see these advances, Sara M. Tolaney, MD, MPH, chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, told attendees at the ESMO Breast Cancer 2024 annual congress…
